IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹738 Cr | ₹547 Cr | ₹471 Cr | ₹884 Cr | ₹1,140 Cr |
What is the latest Consolidated Net Profit of IPCA LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹738 Cr |
| Mar2025 | ₹547 Cr |
| Mar2024 | ₹471 Cr |
| Mar2023 | ₹884 Cr |
| Mar2022 | ₹1,140 Cr |
How is Consolidated Net Profit of IPCA LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹738 Cr | 34.77 | |
| Mar2025 | ₹547 Cr | 16.13 | |
| Mar2024 | ₹471 Cr | -46.69 | |
| Mar2023 | ₹884 Cr | -22.45 | |
| Mar2022 | ₹1,140 Cr | - | |
Compare Consolidated Net Profit of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹47,827.5 Cr | -2.9% | -1.5% | 41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -2.9% |
-1.5% |
41.3% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses